A full-length cDNA clone coding for rat napsin was identified by homology search of the ZooSeq rat EST database (Incyte). Northern blot analysis revealed high expression of napsin mRNA transcripts in kidney, lung and spleen. Western blot analysis showed that rat napsin is expressed in kidney as a 50-kDa, highly glycosylated, monomeric protein. Lysates prepared from human embryonic kidney cells (HEK293) transfected with rat napsin showed increased enzymatic activity which was inhibited by pepstatin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0167-4781(00)00069-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.
Asian Pac J Cancer Prev
January 2022
Department of Surgical Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, (UP), India.
Article Synopsis
- The study focuses on targeted therapy for adenocarcinoma, specifically looking at the expression of PD-L1 and various driver gene mutations (ALK, ROS, EGFR, KRAS, BRAF) in non-small cell lung carcinoma (NSCLC).
- It involved analyzing 100 NSCLC adenocarcinoma cases using immunohistochemistry and real-time PCR to assess the frequency of these markers.
- Findings revealed that 26.36% of cases were PD-L1 positive, with significant associations between mutations and factors like age, gender, smoking status, and overall survival rates.
Kirsten rat sarcoma virus protein overexpression in adenocarcinoma lung: Association with clinicopathological and histomorphological features.
J Carcinog
October 2020
Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India.
Context: Lung cancer is the leading cause of cancer-related deaths worldwide. The constitutive activation of multiple signaling pathways is the major cause of carcinogenesis.
Aims: The study evaluates the frequency of Kirsten rat sarcoma virus (KRAS) protein overexpression and correlates with clinicopathological and histomorphological features in non-small cell lung carcinoma (NSCLC)-adenocarcinoma.
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Biochem Biophys Res Commun
July 2019
Interfaculty Institute of Biochemistry, Eberhard Karls University Tübingen, Germany.
Napsin A is an intracellular aspartic protease and biomarker of various malignancies like lung adenocarcinoma and ovarian clear cell carcinoma, but its detection is usually limited to immunohistochemical techniques gaining excellent information on its distribution but missing information about posttranslational modifications (e.g. maturation state) of the protein.
View Article and Find Full Text PDFBiomarkers in the diagnosis of pleural diseases: a 2018 update.
Ther Adv Respir Dis
March 2019
Pleural Medicine Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Avda Alcalde Rovira Roure 80, 25198 Lleida, Spain.
The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart failure, tuberculosis and, particularly, malignancy. An elevated PF concentration of the amino-terminal fragment of probrain natriuretic peptide (>1500 pg/ml) is a hallmark of acute decompensated heart failure.
View Article and Find Full Text PDFDiagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.
Oncol Lett
January 2018
Department of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Primary pulmonary mucinous adenocarcinoma (PPMA) is an uncommon subtype of lung adenocarcinoma. The present study attempted to clarify the diagnosis, clinicopathological characteristics, and pathologic significance of epithelial growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene (KRAS) mutations and the prognosis of PPMA. A total of 29 patients with PPMA from among 1,469 surgically resected patients with lung adenocarcinoma were enrolled.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!